Richard Pzena Regeneron Pharmaceuticals, Inc. Transaction History

Pzena Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$573.97 - $724.32 $186,540 - $235,404	-325 Reduced 29.04%	794 $547,000
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $106,928 - $144,073	195 Added 21.1%	1,119 $661,000
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $11,902 - $13,968	20 Added 2.21%	924 $645,000
Q4 2021 Feb 04, 2022	SELL	$543.48 - $670.97 $39,674 - $48,980	-73 Reduced 7.47%	904 $571,000
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $78,642 - $93,291	-137 Reduced 12.3%	977 $591,000
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $66,664 - $78,754	-141 Reduced 11.24%	1,114 $622,000
Q1 2021 May 07, 2021	BUY	$446.73 - $548.2 $560,646 - $687,991	1,255 New	1,255 $594,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.